Search NASA⌕ Search

Engineering topics

Islam, M

Publications and source records attributed to Islam, M.

SU-F-T-48: Clinical Implementation of Brachytherapy Planning System for COMS Eye Plaques

Purpose: To commission the Brachytherapy Planning (BP) system (Varian, Palo Alto, CA) for the Collaborative Ocular Melanoma Study (COMS) eye plaques by evaluating dose differences against original plans from Nucletron Planning System (NPS). Methods: NPS system is the primary planning software for COMS-plaques at our facility; however, Brachytherapy Planning 11.0.47 (Varian Medical Systems) is used for secondary check and for seed placement configurations not originally commissioned. Dose comparisons of BP and NPS plans were performed for prescription of 8500 cGy at 5 mm depth and doses to normal structures: opposite retina, inner sclera, macula, optic disk and lens. Plans were calculated for Iodine-125 seeds (OncoSeeds, Model 6711) using COMS-plaques of 10, 12, 14, 16, 18 and 20 mm diameters. An in-house program based on inverse-square was utilized to calculate point doses for comparison as well. Results: The highest dose difference between BP and NPS was 3.7% for the prescription point for all plaques. Doses for BP were higher than doses reported by NPS for all points. The largest percent differences for apex, opposite retina, inner sclera, macula, optic disk, and lens were 3.2%, 0.9%, 13.5%, 20.5%, 15.7% and 2.2%, respectively. The dose calculated by the in-house program was 1.3% higher at the prescription point, and were as high as 42.1%, for points away from the plaque (i.e. opposite retina) when compared to NPS. Conclusion: Doses to the tumor, lens, retina, and optic nerve are paramount for a successful treatment and vision preservation. Both systems are based on TG-43 calculations and assume water medium tissue homogeneity (ρe=1, water medium). Variations seen may result from the different task group versions and/or mathematical algorithms of the software. BP was commissioned to serve as a backup system and it also enables dose calculation in cases where seeds don’t follow conventional placement configuration.

60 APPLIED LIFE SCIENCES↗

SU-F-T-137: Out-Of-Beam Dose for a Compact Double-Scattering Proton Beam Therapy System

Purpose: The out-of-beam dose is important for understanding the peripheral dose in radiation therapy. In proton radiotherapy, the study of out-of-beam dose is scarce and the treatment planning system (TPS) based on pencil beam algorithm cannot accurately predict the out-of-beam dose. This study investigates the out-of-beam dose for the single-room Mevion S250 double scattering proton therapy system using experimentally measured and treatment planning software generated data. The results are compared with those reported for conventional photon beam therapy. However, this study does not incorporate the neutron contribution in the scattered dose. Methods: A total of seven proton treatment plans were generated using Varian Eclipse TPS for three different sites (brain, lung, and pelvis) in an anthropomorphic phantom. Three field sizes of 5×5, 10×10, and 20×20 cm{sup 2} (lung only) with typical clinical range (13.3–22.8 g/cm{sup 2}) and modulation widths (5.3–14.0 g/cm{sup 2}) were used. A single beam was employed in each treatment plan to deliver a dose of 181.8 cGy (200.0 cGy (RBE)) to the selected target. The out-of-beam dose was measured at 2.0, 5.0, 10.0, and 15.0 cm from the beam edge in the phantom using a thimble chamber (PTW TN31010). Results: The out-of-beam dose generally increased with field size, range, and volume irradiated. For all the plans, the scattered dose sharply fell off with distance. At 2.0 cm, the out-of-beam dose ranged from 0.35% to 2.16% of the delivered dose; however, the dose was clinically negligible (<0.3%) at a distance of 5.0 cm and greater. In photon therapy, the slightly greater out-of-beam dose was reported (TG36; 4%, 2%, and 1% for 2.0, 5.0, and 10.0 cm, respectively, using 6 MV beam). Conclusion: The measured out-of-beam dose in proton therapy excluding neutron contribution was observed higher than the TPS calculated dose and comparable to that of photon beam therapy.

60 APPLIED LIFE SCIENCES↗

SU-F-T-143: Implementation of a Correction-Based Output Model for a Compact Passively Scattered Proton Therapy System

Purpose: To commission and investigate the accuracy of an output (cGy/MU) prediction model for a compact passively scattered proton therapy system. Methods: A previously published output prediction model (Sahoo et al, Med Phys, 35, 5088–5097, 2008) was commissioned for our Mevion S250 proton therapy system. This model is a correction-based model that multiplies correction factors (d/MUwnc=ROFxSOBPF xRSFxSOBPOCFxOCRxFSFxISF). These factors accounted for changes in output due to options (12 large, 5 deep, and 7 small), modulation width M, range R, off-center, off-axis, field-size, and off-isocenter. In this study, the model was modified to ROFxSOBPFxRSFxOCRxFSFxISF-OCFxGACF by merging SOBPOCF and ISF for simplicity and introducing a gantry angle correction factor (GACF). To commission the model, outputs over 1,000 data points were taken at the time of the system commissioning. The output was predicted by interpolation (1D for SOBPF, FSF, and GACF; 2D for RSF and OCR) with inverse-square calculation (ISF-OCR). The outputs of 273 combinations of R and M covering total 24 options were measured to test the model. To minimize fluence perturbation, scattered dose from range compensator and patient was not considered. The percent differences between the predicted (P) and measured (M) outputs were calculated to test the prediction accuracy ([P-M]/Mx100%). Results: GACF was required because of up to 3.5% output variation dependence on the gantry angle. A 2D interpolation was required for OCR because the dose distribution was not radially symmetric especially for the deep options. The average percent differences were −0.03±0.98% (mean±SD) and the differences of all the measurements fell within ±3%. Conclusion: It is concluded that the model can be clinically used for the compact passively scattered proton therapy system. However, great care should be taken when the field-size is less than 5×5 cm{sup 2} where a direct output measurement is required due to substantial output change by irregular block shape.

60 APPLIED LIFE SCIENCES↗

SU-F-T-160: Commissioning of a Single-Room Double-Scattering Proton Therapy System

Purpose: To report the detailed commissioning experience for a compact double-scattering Mevion S250 proton therapy system at a University Cancer Center site. Methods: The commissioning of the proton therapy system mainly consisted of ensuring integrity of mechanical and imaging system, beam data collection, and commissioning of a treatment planning system (TPS). First, mechanical alignment and imaging were tested including safety, interlocks, positional accuracy of couch and gantry, image quality, mechanical and imaging isocenter and so on. Second, extensive beam data (outputs, PDDs, and profiles) were collected and analyzed through effective sampling of range (R) and modulation width (M) from 24 beam options. Three different output (cGy/MU) prediction models were also commissioned as primary and secondary MU calculation tool. Third, the Varian Eclipse TPS was commissioned through five sets of data collections (in-water Bragg peak scans, in-air longitudinal fluence scans, in-air lateral profiles, in-air half-beam profiles, and an HU-to-stopping-power conversion curve) and accuracy of TPS calculation was tested using in-water scans and dose measurements with a 2D array detector with block and range compensator. Finally, an anthropomorphic phantom was scanned and heterogeneity effects were tested by inserting radiochromic films in the phantom and PET activation scans for range verification in conjunction with end-to-end test. Results: Beam characteristics agreed well with the vendor specifications; however, minor mismatches in R and M were found in some measurements during the beam data collection. These were reflected into the TPS commissioning such that the TPS could accurately predict the R and M within tolerance levels. The output models had a good agreement with measured outputs (<3% error). The end-to-end test using the film and PET showed reasonably the TPS predicted dose, R and M in heterogeneous medium. Conclusion: The proton therapy system was successfully commissioned and was released for clinical use.

60 APPLIED LIFE SCIENCES↗

SU-F-T-204: A Preliminary Approach of Reducing Contralateral Breast and Heart Dose in Left Sided Whole Breast Cancer Patients Utilizing Proton Beams

Purpose: To investigate the plan quality and feasibility of a hybrid plan utilizing proton and photon fields for superior coverage in the internal mammary (IM) and supraclavicular (S/C) regions while minimizing heart and contralateral breast dose for the left-sided whole breast cancer patient treatment. Methods: This preliminary study carried out on single left-sided intact breast patient involved IM and S/C nodes. The IM and S/C node fields of the 5-Field 3DCRT photon-electron base plan were replaced by two proton fields. These two along with two Field-in-Field tangential photon fields were optimized for comparable dose coverage. The treatment plans were done using Eclipse TPS for the total dose of 46Gy in 23 fractions with 95% of the prescription dose covering 95% of the RTOG PTV. The 3DCRT photon-electron and 4-Field photon-proton hybrid plans were compared for the PTV dose coverage as well as dose to OARs. Results: The overall RTOG PTV coverage for proton-hybrid and 3DCRT plan was comparable (95% of prescription dose covers 95% PTV volume). In proton-hybrid plan, 99% of IM volume received 100% dose whereas in 3DCRT only 77% received 100% dose. For S/C regions, 97% and 77% volume received 100% prescription dose in proton-hybrid and 3DCRT plans, respectively. The heart mean dose, V3Gy(%), and V5Gy(%) was 2.2Gy, 14.4%, 9.8% for proton-hybrid vs. 4.20 Gy, 21.5%, and 39% for 3DCRT plan, respectively. The maximum dose to the contralateral breast was 39.75Gy for proton-hybrid while 56.87Gy for 3DCRT plan. The mean total lung dose, V20Gy(%), and V30Gy(%) was 5.68Gy, 11.3%, 10.5% for proton-hybrid vs. 5.90Gy, 9.8%, 7.2% for 3DCRT, respectively. Conclusion: The protonhybrid plan can offer better dose coverage to the involved lymphatic tissues while lower doses to the heart and contralateral breast. More treatment plans are currently in progress before being implemented clinically.

60 APPLIED LIFE SCIENCES↗

SU-E-T-315: Dosimetric Effects of Couch Top Shift On VMAT Delivery in Absence of Indexing

Purpose: To investigate dosimetric effects of couch top shift for volumetric-modulated arc therapy (VMAT) in absence of indexing of immobilization devices. Methods: A total of twelve VMAT treatment plans were selected from three regions (lung, abdomen, and pelvis) to account for the variation of the patient position relative to the couch top. The treatment plans were generated using the Varian Eclipse system. A pinpoint ionization chamber (PTW TN31014) was placed at the center of 16-cm solid water phantom and the dose was delivered using the Varian TrueBeam STx with BrainLAB ExacTrac couch top. To simulate the day-to-day variation of the patient position relative to couch top, the couch top was laterally shifted up to 50 mm, with an increment of 5 mm from 0 to 20 mm; and of 10 mm afterwards, and the phantom was moved back to 0 cm shift for measurement. The dose was also delivered using a Varian tennis racket grid insert at 0 cm shift to simulate the absence of couch top. The treatment plans were delivered with 6, 10, and 15 MV photons using the same leaf sequencing to investigate the energy dependence of couch top shift. The dose difference was normalized to 0 cm shift for the regular couch top for comparison. Results: The percent difference of dose was found to increase with lateral shift for all energies; however, the average differences were close to 0% and the maximum difference was within 1% along the lateral shifts. The differences with the absence of couch top were 2.2±0.5% (6MV), 1.7±0.3% (10MV), and 1.6±0.2% (15MV), respectively. Conclusion: The inclusion of couch top is recommended in treatment planning to minimize the dosimetric uncertainty between calculated and delivered dose even in absence of indexing of immobilization devices in VMAT delivery.

60 APPLIED LIFE SCIENCES↗

SU-E-T-354: Efficient and Enhanced QA Testing of Linear Accelerators Using a Real-Time Beam Monitor

Purpose: To investigate the feasibility of performing routine QA tests of linear accelerators (Linac) using the Integral Quality Monitoring (IQM) system. The system, consisting of a 1-D sensitivity gradient large area ion-chamber mounted at the collimator, allows automatic collection and analysis of beam data. Methods: The IQM was investigated to perform several QA constancy tests, similar to those recommended by AAPM TG142, of a Linac including: beam output, MLC calibration, beam symmetry, relative dose factor (RDF), dose linearity, output as a function of gantry angle and dose rate. All measurements by the IQM system accompanied a reference measurement using a conventional dosimetry system and were performed on an Elekta Infinity Linac with Agility MLC. The MLC calibration check is done using a Picket-Fence type 2×10cm{sup 2} field positioned at different off-axis locations along the chamber gradient. Beam symmetry constancy values are established by signals from an 4×4cm{sup 2} aperture located at various off-axis positions; the sensitivity of the test was determined by the changes in the signals in response to a tilt in the beam. The data for various square field sizes were used to develop a functional relationship with RDF. Results: The IQM tracked the beam output well within 1% of the reference ion-chamber readings. The Picket-Fence type field test detected a 1mm shift error of one MLC bank. The system was able to detect 2.5% or greater beam asymmetry. The IQM results for all other QA tests were found to agree with the reference values to within 0.5%. Conclusion: It was demonstrated that the IQM system can effectively monitor the Linac performance parameters for the purpose of routine QA constancy tests. With minimum user interactions a comprehensive set of tests can be performed efficiently, allowing frequent monitoring of the Linac. The presenting author’s salary is funded by the manufacturer of the QA device. All the other authors have financial interests with the commercialization of this QA device.

07 ISOTOPE AND RADIATION SOURCES↗

SU-E-T-454: Impact of Air Gap On PDDs of 6 MV Photon Beam for Various Field Sizes in Inhomogeneous Phantoms

Purpose: To investigate how the shape of air gap and its size will impact the percent depth doses (PDDs) of a 6MV photon beam for various field sizes. Methods: Two in-house phantoms were manufactured containing rectangular (phantom A) and circular (phantom B) air gaps. Both phantoms A and B were composed of same top layer (solid-water; 30×30cm{sup 2},5cm thickness) and bottom layer (solid-water; 30×30cm {sup 2},8cm thickness), but middle layer was varied to observe air gap effects and scatter contribution to the measurement point. In phantom A, a rectangular shaped air gap (30×30cm{sup 2},7cm thickness) was created by placing Styrofoam blocks between top and bottom layers of the phantom. In phantom B, middle layer was replaced by “inhomogenous block”, composed of acrylic plate (30×30cm{sup 2}, 4cm thickness) followed by PVC(30×30cm{sup 2},3cm thickness). Additionally, circular air gap was created by drilling a hole (diameter=2.8cm, length=7cm) at the center of “inhomogenous block”. In both phantoms, measurement readings were obtained at 13cm depth (i.e., 1cm after air gap) and depth of maximum dose(6MV energy; 100 MUs; field sizes ranged from 3×3cm{sup 2} to 10×10cm{sup 2}). The PDDs at 13cm depth were compared in both phantoms. Results: The measurements in both phantoms A and B showed an almost linear increase in PDDs with increasing field size, especially for smaller field sizes (from 3×3 to 7×7cm{sup 2}). For each field size, the PDD in phantom A was smaller compared to the one in phantom B. The difference in PDDs between two phantoms decreased with an increase in field size as the PDD difference decreased from 9.0% to 6.4%. Conclusion: The shape and size of air gap affect the PDD measurements in secondary build-up region as 6 MV primary beam traverses through the center of air gap. The scatter contribution due to increase in field size was more noticeable for field sizes ≤7×7cm{sup 2}.

60 APPLIED LIFE SCIENCES↗

SU-E-T-542: Measurement of Internal Neutrons for Uniform Scanning Proton Beams

Purpose: In proton radiotherapy, the production of neutrons is a wellknown problem since neutron exposure can lead to increased risk of secondary cancers later in the patient’s lifetime. The assessment of neutron exposure is, therefore, important for the overall quality of proton radiotherapy. This study investigates the secondary neutrons created inside the patient from uniform scanning proton beams. Methods: Dose equivalent due to secondary neutrons was measured outside the primary field as a function of distance from beam isocenter at three different angles, 45, 90 and 135 degree, relative to beam axis. Plastic track nuclear detector (CR-39 PNTD) was used for the measurement of neutron dose. Two experimental configurations, in-air and cylindrical-phantom, were designed. In a cylindrical-phantom configuration, a cylindrical phantom of 5.5 cm diameter and 35 cm long was placed along the beam direction and in an in-air configuration, no phantom was used. All the detectors were placed at nearly identical locations in both configurations. Three proton beams of range 5 cm, 18 cm, and 32 cm with 4 cm modulation width and a 5 cm diameter aperture were used. The contribution from internal neutrons was estimated from the differences in measured dose equivalent between in-air and cylindrical-phantom configurations at respective locations. Results: The measured ratio of neutron dose equivalent to the primary proton dose (H/D) dropped off with distance and ranged from 27 to 0.3 mSv/Gy. The contribution of internal neutrons near the treatment field edge was found to be up to 64 % of the total neutron exposure. As the distance from the field edge became larger, the external neutrons from the nozzle appear to dominate and the internal neutrons became less prominent. Conclusion: This study suggests that the contribution of internal neutrons could be significant to the total neutron dose equivalent.

61 RADIATION PROTECTION AND DOSIMETRY↗

SU-E-T-568: Neutron Dose Survey of a Compact Single Room Proton Machine

Purpose: To ensure acceptable radiation limits are maintained for those working at and near the machine during its operation, a comprehensive radiation survey was performed prior to the clinical release of Mevion S250 compact proton machine at Stephenson Oklahoma Cancer Center. Methods: The Mevion S250 proton therapy system consists of the following: a superconducting cyclotron to accelerate the proton particles, a passive double scattering system for beam shaping, and paired orthogonal x-ray imaging systems for patient setup and verification via a 6D robotic couch. All equipment is housed within a single vault of compact design. Two beam delivery applicators are available for patient treatment, offering field sizes of as great as 14 cm and 25 cm in diameter, respectively. Typical clinical dose rates are between 1 and 2 Gy/min with a fixed beam energy of 250 MeV. The large applicator (25 cm in diameter) was used in conjunction with a custom cut brass aperture to create a 20 cm x 20 cm field size at beam isocenter. A 30 cm − 30 cm − 35 cm high density plastic phantom was placed in the beam path to mimic the conditions creating patient scatter. Measurements integrated-ambient-neutron-dose-equivalence were made with a SWENDII detector. Gantry angles of 0, 90 and 180 degrees, with a maximum dose rate of 150 MU/min (for large applicator) and beam configuration of option 1 (range 25 cm and 20 cm modulation), were selected as testing conditions. At each point of interest, the highest reading was recorded at 30 cm from the barrier surface. Results: The highest neutron dose was estimated to be 0.085 mSv/year at the console area. Conclusion: All controlled areas are under 5 mSv/year and the uncontrolled areas are under 1 mSv/year. The radiation protection provided by the proton vault is of sufficient quality.

61 RADIATION PROTECTION AND DOSIMETRY↗

SU-E-T-304: Study of Secondary Neutrons From Uniform Scanning Proton Beams

Purpose: Secondary neutrons are unwanted byproducts from proton therapy and exposure from secondary radiation during treatment could increase risk of developing a secondary cancer later in a patient's lifetime. The purpose of this study is to investigate secondary neutrons from uniform scanning proton beams under various beam conditions using both measurements and Monte Carlo simulations. Methods: CR-39 Plastic Track Nuclear Detectors (PNTD) were used for the measurement. CR-39 PNTD has tissue like sensitivity to the secondary neutrons but insensitive to the therapeutic protons. In this study, we devised two experimental conditions: a) hollow-phantom; phantom is bored with a hollow cylinder along the direction of the beam so that the primary proton passes through the phantom without interacting with the phantom material, b) cylindrical-phantom; a solid cylinder of diameter close to the beam diameter is placed along the beam path. CR-39 PNTDs were placed laterally inside a 60X20X35 cm3 phantom (hollow-phantom) and in air (cylindrical-phantom) at various angles with respect to the primary beam axis. We studied for three different proton energies (78 MeV, 162 MeV and 226 MeV), using a 4 cm modulation width and 5cm diameter brass aperture for the entire experiment and simulation. A comparison of the experiment was performed using the Monte Carlo code FLUKA. Results: The measured secondary neutron dose equivalent per therapeutic primary proton dose (H/D) ranges from 2.1 ± 0.2 to 25.42 ± 2.3 mSv/Gy for the hollow phantom study, and 2.7 ± 0.3 to 46.4 ± 3.4 mSv/Gy for the cylindrical phantom study. Monte Carlo simulations predicated neutron dose equivalent from measurements within a factor of 5. Conclusion: The study suggests that the production of external neutrons is significantly higher than the production of internal neutrons.

07 ISOTOPE AND RADIATION SOURCES↗

SU-E-T-586: Field Size Dependence of Output Factor for Uniform Scanning Proton Beams: A Comparison of TPS Calculation, Measurement and Monte Carlo Simulation

Purpose: Output dependence on field size for uniform scanning beams, and the accuracy of treatment planning system (TPS) calculation are not well studied. The purpose of this work is to investigate the dependence of output on field size for uniform scanning beams and compare it among TPS calculation, measurements and Monte Carlo simulations. Methods: Field size dependence was studied using various field sizes between 2.5 cm diameter to 10 cm diameter. The field size factor was studied for a number of proton range and modulation combinations based on output at the center of spread out Bragg peak normalized to a 10 cm diameter field. Three methods were used and compared in this study: 1) TPS calculation, 2) ionization chamber measurement, and 3) Monte Carlos simulation. The XiO TPS (Electa, St. Louis) was used to calculate the output factor using a pencil beam algorithm; a pinpoint ionization chamber was used for measurements; and the Fluka code was used for Monte Carlo simulations. Results: The field size factor varied with proton beam parameters, such as range, modulation, and calibration depth, and could decrease over 10% from a 10 cm to 3 cm diameter field for a large range proton beam. The XiO TPS predicted the field size factor relatively well at large field size, but could differ from measurements by 5% or more for small field and large range beams. Monte Carlo simulations predicted the field size factor within 1.5% of measurements. Conclusion: Output factor can vary largely with field size, and needs to be accounted for accurate proton beam delivery. This is especially important for small field beams such as in stereotactic proton therapy, where the field size dependence is large and TPS calculation is inaccurate. Measurements or Monte Carlo simulations are recommended for output determination for such cases.

07 ISOTOPE AND RADIATION SOURCES↗